Dicerna narrows focus for kidney drug after mixed data, setting up head-to-head market battle with rival Alnylam
Dicerna narrows focus for kidney drug after mixed data, setting [...]
Atea and Roche’s COVID-19 antiviral flunks phase 2, prompting switch that will delay pivotal data
Atea and Roche’s COVID-19 antiviral flunks phase 2, prompting switch [...]
A new target in multiple myeloma? TAK1 blocker boosts chemo’s cancer-killing power in preclinical study
A new target in multiple myeloma? TAK1 blocker boosts chemo’s [...]
FDA rejects Omeros transplant drug over difficulties estimating its effect
FDA rejects Omeros transplant drug over difficulties estimating its effect [...]
Biogen’s ALS drug has failed phase 3. Will FDA approve anyway?
Biogen’s ALS drug has failed phase 3. Will FDA approve [...]
Greenwood takes the top job at Kojin Therapeutics, leading an all-woman biotech C-suite
Greenwood takes the top job at Kojin Therapeutics, leading an [...]
Inhalable anti-COVID-19 antibody from TFF and Augmenta tamps down viral load in hamsters
Inhalable anti-COVID-19 antibody from TFF and Augmenta tamps down viral [...]
AstraZeneca delivers rare win for treme in liver cancer, bouncing back from flops to beat Bayer’s Nexavar
AstraZeneca delivers rare win for treme in liver cancer, bouncing [...]
Chinese biopharma powerhouse continues charge into siRNA with Silence R&D pact
Chinese biopharma powerhouse continues charge into siRNA with Silence R&D [...]
Protein that manipulates gene expression inside the cell nucleus could inspire new RSV drugs, vaccines
Protein that manipulates gene expression inside the cell nucleus could [...]